Page last updated: 2024-09-04

jte 522 and Pancreatic Neoplasms

jte 522 has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dono, K; Fujiwara, Y; Hayashi, N; Hiraoka, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Tsujie, M; Umeshita, K; Yamamoto, H1

Other Studies

1 other study(ies) available for jte 522 and Pancreatic Neoplasms

ArticleYear
Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor.
    Clinical & experimental metastasis, 2003, Volume: 20, Issue:7

    Topics: Benzenesulfonates; Cell Adhesion; Cell Division; Cell Movement; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation; Humans; Isoenzymes; Matrix Metalloproteinases; Membrane Proteins; Neoplasm Invasiveness; Oxazoles; Pancreatic Neoplasms; Prostaglandin-Endoperoxide Synthases; Tumor Cells, Cultured

2003